Clinical Trials Sponsored by ALK-Abello A/S

Total 80 results

ALK-Abelló A/S

Enrolling by invitation

Evaluate Measurement Instruments Relevance in Assessing Effectiveness of ACARIZAX® in House Dust Mite Allergic Rhinitis

Allergic Asthma | Allergic Rhinitis Due to House Dust Mite

China
ALK-Abelló A/S

Completed

Molecular and Cellular Mechanism in Rhinitis Allergic Patients Treated With GRAZAX® (GT-20)

Allergic Rhinoconjunctivitis

Spain
ALK-Abelló A/S

Completed

Efficacy and Safety of Grass Sublingual Tablet in Children and Adolescents (P05239 AM3)(COMPLETED)

Allergy | Rhinitis | Conjunctivitis | Rhinoconjunctivitis
ALK-Abelló A/S

Completed

A Survey of Adults and Children With Allergic Rhinoconjunctivitis (MK-7243-021) (AIRS)

Allergic Rhinoconjunctivitis
ALK-Abelló A/S

Completed

A Study of Ragweed (Ambrosia Artemisiifolia) Allergy Immunotherapy Tablet in Adults With Ragweed Allergies (P05751)

Allergy
ALK-Abelló A/S

Completed

Grazax Asthma Prevention (GAP)

Allergic Rhinitis

Finland
ALK-Abelló A/S

Completed

Efficacy and Safety Trial of Pangramin SLIT HDM-mix in Subjects With House Dust Mite Induced Rhinitis

Allergic Rhinitis

China
ALK-Abelló A/S

Completed

Evaluation of the Efficacy and Safety of AVANZ® Phleum Pratense in Grass Pollen-induced Allergic Rhinitis During Controlled Exposure in an Environmental Challenge Chamber (AV-G-03)

Grass Pollen Induced Allergic Rhinoconjunctivitis

Germany
ALK-Abelló A/S

Completed

An Open Trial to Assess the Tolerability of AVANZ Mite Mix Immunotherapy (AV-M-01)

Allergic Rhinitis Due to Dust Mite

Spain
ALK-Abelló A/S

Completed

Avanz Phleum Pratense Maintenance Dose

Allergic Rhinoconjunctivitis

Germany
ALK-Abelló A/S

Completed

A Trial Evaluating Tolerability of Grazax Treatment in Combination With Antihistamine (GT-19)

Allergic Rhinoconjunctivitis

Germany
ALK-Abelló A/S

Completed

Compliance to the Treatment With GRAZAX® Tablets in Patients With Seasonal Grass Pollen Rhinoconjunctivitis (GT-17)

Allergic Rhinitis | Grass Allergy

Italy
ALK-Abelló A/S

Completed

A Phase III Trial Assessing the Pharmacodynamic Effect and the Tolerability of Grazax Treatment

Grass Pollen Allergy

Denmark
ALK-Abelló A/S

Terminated

Comparison of Different Up-dosing Schedules With Osiris

Allergic Rhinitis

Poland
ALK-Abelló A/S

Completed

Safety of ALK Ragweed Tablet

Allergy

United States
ALK-Abelló A/S

Completed

Mite Asthma Pediatric Immunotherapy Trial (MAPIT)

Allergic Rhinitis Due to House Dust Mite | Allergic Asthma Due to Dermatophagoides Farinae | Allergic Asthma Due to Dermatophagoides Pteronyssinus

Poland, United Kingdom, Spain, United States, Russian Federation, Hungary, France, Bulgaria, Germany
ALK-Abelló A/S

Terminated

A Research Study in Chinese People With Allergy to House Dust Mites, Using an Environmental Exposure Chamber (QUEST)

Allergic Rhinoconjunctivitis

Austria, China
ALK-Abelló A/S

Completed

Impact of AIT on Allergic Rhinitis and Asthma

Allergy | Respiratory Disease

Denmark
ALK-Abelló A/S

Completed

A Study of SCH 697243 in Participants With Grass Pollen Allergy Symptoms, With or Without Asthma (P08067)

Conjunctivitis | Rhinitis Allergic
ALK-Abelló A/S

Completed

Safety Study of MK-3641 and MK-7243 Co-administered in Adult Participants With Ragweed and Grass Pollen Induced Allergic Rhinitis (P08607, MK-3641-006)

Rhinitis, Allergic, Seasonal
ALK-Abelló A/S

Completed

Efficacy and Long-Term Safety of Ragweed (Ambrosia Artemisiifolia) Sublingual Tablet in Adults With a History of Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (Study P05233)(COMPLETED)

Conjunctivitis | Rhinitis; Allergic, With Asthma
ALK-Abelló A/S

Completed

Efficacy and Long-Term Safety of Ragweed (Ambrosia Artemisiifolia) Sublingual Tablet (SCH 39641) in Adults With a History of Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (Study P05234)

Rhinitis, Allergic | Conjunctivitis
ALK-Abelló A/S

Completed

Safety Study of Ragweed Allergy Immunotherapy Tablet in Subjects 50 Years of Age and Older (Study P06081)

Allergy | Rhinitis | Conjunctivitis | Rhinoconjunctivitis
ALK-Abelló A/S

Completed

Retrospective Record Review of Adults and Children Advised for Allergen Immunotherapy (MK-7243-022)

Perennial Allergic Rhinitis | Seasonal Allergic Rhinitis
ALK-Abelló A/S

Completed

A Trial of Grazax in Subjects With Hayfever

Allergy

United States
ALK-Abelló A/S

Completed

A Dose Response Evaluation of SLITone Ultra HDM Mix Immunotherapy (SUMMIT)

Allergic Rhinitis

France
ALK-Abelló A/S

Completed

An Open Trial to Assess the Tolerability of AVANZ Olive Immunotherapy

Allergic Rhinitis Due to Olea Europaea Pollen

Spain
ALK-Abelló A/S

Completed

A Trial of the ALK Grass Tablet in Subjects With Hayfever

Allergy

Denmark
ALK-Abelló A/S

Completed

Efficacy and Safety Trial of the ALK HDM Tablet in House Dust Mite Allergic Subjects

Asthma

Denmark
ALK-Abelló A/S

Completed

Assessment of Grazax® Treatment Compliance

Allergy

Austria
ALK-Abelló A/S

Completed

Changes in the Immune Response and Skin Reactivity of Grass Pollen Allergic Patients Treated With ALK Grass Tablets

Allergy

Spain
ALK-Abelló A/S

Recruiting

Observational Study of Allergic Rhinitis in Children (ORACLE)

Allergic Rhinitis

France
ALK-Abelló A/S

Active, not recruiting

House Dust Mite Allergy Trial In Children (MATIC)

Allergic Rhinitis Due to Dermatophagoides Farinae | Allergic Rhinitis Due to Dermatophagoides Pteronyssinus | Allergic Rhinitis Due to House Dust Mite

Spain, Russian Federation, United States, Poland, Bulgaria, Canada, France, Germany, Lithuania, Slovakia, Ukraine
ALK-Abelló A/S

Completed

Molecular and Cellular Mechanism in the Course of Immunotherapy With a Phleum Pratense Oral Lyophilisate

Allergic Rhinitis Due to Grass Pollens

Spain
ALK-Abelló A/S

Completed

Efficacy and Safety of Grass Sublingual Tablet in Adults (P05238 AM3)(COMPLETED)

Allergy | Rhinitis | Conjunctivitis | Rhinoconjunctivitis
ALK-Abelló A/S

Completed

A One Year Trial Evaluating the Safety and Efficacy of the ALK House Dust Mite Allergy Tablet (MT-06)

House Dust Mite Allergy

France
ALK-Abelló A/S

Completed

Intraseasonal Short-time Up-dosing With Alutard SQ Grasses

Allergy

Germany
ALK-Abelló A/S

Completed

Efficacy and Safety Trial of ALK-depot SQ Mites in Subjects With Atopic Dermatitis

Atopic Dermatitis

Germany
ALK-Abelló A/S

Completed

An Open Trial to Assess the Tolerability of AVANZ Phleum Pratense Immunotherapy

Allergic Rhinoconjunctivitis

Spain
ALK-Abelló A/S

Completed

An Open Trial to Assess the Tolerability of AVANZ® Salsola Immunotherapy (AV-X-02)

Allergic Rhinoconjunctivitis Due to Salsola Kali Pollen

Spain
ALK-Abelló A/S

Completed

An Open Trial to Assess the Tolerability of AVANZ® Cupressus Immunotherapy

Allergic Rhinoconjunctivitis

Spain
ALK-Abelló A/S

Completed

A Dose-response Evaluation of ALK (the Sponsor) Tree Allergy Immunotherapy Tablet

Birch Pollen Allergy

Finland, Netherlands
ALK-Abelló A/S

Completed

Efficacy and Safety Trial of SLITone(TM) Birch in Subjects With Hayfever

Allergy

Germany
ALK-Abelló A/S

Completed

Study on Pharmacodynamic Parameter and Tolerability With Subcutaneous Immunotherapy in Grass Pollen Allergic Patients

Asthma | Rhinitis | Conjunctivitis

Germany
ALK-Abelló A/S

Completed

Efficacy and Tolerability of Two Different Administration Routes With SLITonePLUS Birch

Allergy

Germany
ALK-Abelló A/S

Completed

Tolerability of Grazax in Patients With Hayfever in Real Life Settings (GRAAL)

Allergic Rhinoconjunctivitis

France
ALK-Abelló A/S

Completed

Efficacy of SLITone in House Dust Mite Allergic Patients

Allergy

Spain
ALK-Abelló A/S

Completed

Efficacy and Safety of Grazax in Children

Allergy

Germany
ALK-Abelló A/S

Completed

Efficacy and Safety Trial of Subcutaneous Immunotherapy in Mite Induced Asthma

Allergic Asthma

Spain
ALK-Abelló A/S

Completed

Tolerability of ALK Tree Tablet

Allergy

Denmark

3

Subscribe